Updates are available Correction dated 2024-01-11
Click to view Correction: https://doi.org/10.1038/s41589-024-01546-z
-
Authors
Wozniak, Jacob M.
Li, Weichao http://orcid.org/0000-0001-6875-7315
Governa, Paolo http://orcid.org/0000-0002-5976-780X
Chen, Li-Yun
Jadhav, Appaso
Dongre, Ashok
Forli, Stefano http://orcid.org/0000-0002-5964-7111
Parker, Christopher G. http://orcid.org/0000-0001-8509-9289
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1U19AII71443-01, R01AI156258, T32 AI007244, 1U19AII71443-01)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM069832)
- License Information
-
More Information
Article History
Received: 5 December 2022
Accepted: 29 November 2023
First Online: 2 January 2024
Change Date: 11 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41589-024-01546-z
Competing interests
: C.G.P. is a cofounder and scientific advisor to Belharra Therapeutics, a biotechnology company interested in using chemical proteomic methods to develop small-molecule therapeutics. The other authors declare no competing interests.
